Global Peripheral Drug-Coated Balloon Market Research Report 2023
Drug-coated balloons (DCB) have been introduced to improve patency rates following endovascular intervention for lower extremity PAD. They have gained popularity among endovascular specialists due to its ease of use and the concept of “leave nothing behind”.
According to QYResearch’s new survey, global Peripheral Drug-Coated Balloon market is projected to reach US$ 1363.8 million in 2029, increasing from US$ 863 million in 2022, with the CAGR of 6.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Peripheral Drug-Coated Balloon market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Peripheral Drug-Coated Balloon market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global Peripheral Drug-Coated Balloon market is projected to reach US$ 1363.8 million in 2029, increasing from US$ 863 million in 2022, with the CAGR of 6.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Peripheral Drug-Coated Balloon market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Peripheral Drug-Coated Balloon market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Cordis
- Defibtech
- Abbott Laboratories
- REVA Medical
- Shimadzu
- Opto Circuits
- Biotronik
- Endologix
- SMT
- Philips Healthcare
- Elixir Medical
- CorMatrix Cardiovascular
- Advanced Cardiac Therapeutics
- Edwards Lifesciences
- Impulse Dynamics
- Stereotaxis
- Paclitaxel
- Sirolimus
- Others
- Hospital
- Clinic
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 PERIPHERAL DRUG-COATED BALLOON MARKET OVERVIEW
1.1 Product Overview and Scope of Peripheral Drug-Coated Balloon
1.2 Peripheral Drug-Coated Balloon Segment by Type
1.2.1 Global Peripheral Drug-Coated Balloon Market Value Comparison by Type (2023-2029)
1.2.2 Paclitaxel
1.2.3 Sirolimus
1.2.4 Others
1.3 Peripheral Drug-Coated Balloon Segment by Application
1.3.1 Global Peripheral Drug-Coated Balloon Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Peripheral Drug-Coated Balloon Market Size Estimates and Forecasts
1.4.1 Global Peripheral Drug-Coated Balloon Revenue 2018-2029
1.4.2 Global Peripheral Drug-Coated Balloon Sales 2018-2029
1.4.3 Global Peripheral Drug-Coated Balloon Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 PERIPHERAL DRUG-COATED BALLOON MARKET COMPETITION BY MANUFACTURERS
2.1 Global Peripheral Drug-Coated Balloon Sales Market Share by Manufacturers (2018-2023)
2.2 Global Peripheral Drug-Coated Balloon Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Peripheral Drug-Coated Balloon Average Price by Manufacturers (2018-2023)
2.4 Global Peripheral Drug-Coated Balloon Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Peripheral Drug-Coated Balloon, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peripheral Drug-Coated Balloon, Product Type & Application
2.7 Peripheral Drug-Coated Balloon Market Competitive Situation and Trends
2.7.1 Peripheral Drug-Coated Balloon Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Peripheral Drug-Coated Balloon Players Market Share by Revenue
2.7.3 Global Peripheral Drug-Coated Balloon Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PERIPHERAL DRUG-COATED BALLOON RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Peripheral Drug-Coated Balloon Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Peripheral Drug-Coated Balloon Global Peripheral Drug-Coated Balloon Sales by Region: 2018-2029
3.2.1 Global Peripheral Drug-Coated Balloon Sales by Region: 2018-2023
3.2.2 Global Peripheral Drug-Coated Balloon Sales by Region: 2024-2029
3.3 Global Peripheral Drug-Coated Balloon Global Peripheral Drug-Coated Balloon Revenue by Region: 2018-2029
3.3.1 Global Peripheral Drug-Coated Balloon Revenue by Region: 2018-2023
3.3.2 Global Peripheral Drug-Coated Balloon Revenue by Region: 2024-2029
3.4 North America Peripheral Drug-Coated Balloon Market Facts & Figures by Country
3.4.1 North America Peripheral Drug-Coated Balloon Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Peripheral Drug-Coated Balloon Sales by Country (2018-2029)
3.4.3 North America Peripheral Drug-Coated Balloon Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Peripheral Drug-Coated Balloon Market Facts & Figures by Country
3.5.1 Europe Peripheral Drug-Coated Balloon Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Peripheral Drug-Coated Balloon Sales by Country (2018-2029)
3.5.3 Europe Peripheral Drug-Coated Balloon Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peripheral Drug-Coated Balloon Market Facts & Figures by Country
3.6.1 Asia Pacific Peripheral Drug-Coated Balloon Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Peripheral Drug-Coated Balloon Sales by Country (2018-2029)
3.6.3 Asia Pacific Peripheral Drug-Coated Balloon Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Peripheral Drug-Coated Balloon Market Facts & Figures by Country
3.7.1 Latin America Peripheral Drug-Coated Balloon Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Peripheral Drug-Coated Balloon Sales by Country (2018-2029)
3.7.3 Latin America Peripheral Drug-Coated Balloon Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Peripheral Drug-Coated Balloon Market Facts & Figures by Country
3.8.1 Middle East and Africa Peripheral Drug-Coated Balloon Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Peripheral Drug-Coated Balloon Sales by Country (2018-2029)
3.8.3 Middle East and Africa Peripheral Drug-Coated Balloon Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Peripheral Drug-Coated Balloon Sales by Type (2018-2029)
4.1.1 Global Peripheral Drug-Coated Balloon Sales by Type (2018-2023)
4.1.2 Global Peripheral Drug-Coated Balloon Sales by Type (2024-2029)
4.1.3 Global Peripheral Drug-Coated Balloon Sales Market Share by Type (2018-2029)
4.2 Global Peripheral Drug-Coated Balloon Revenue by Type (2018-2029)
4.2.1 Global Peripheral Drug-Coated Balloon Revenue by Type (2018-2023)
4.2.2 Global Peripheral Drug-Coated Balloon Revenue by Type (2024-2029)
4.2.3 Global Peripheral Drug-Coated Balloon Revenue Market Share by Type (2018-2029)
4.3 Global Peripheral Drug-Coated Balloon Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Peripheral Drug-Coated Balloon Sales by Application (2018-2029)
5.1.1 Global Peripheral Drug-Coated Balloon Sales by Application (2018-2023)
5.1.2 Global Peripheral Drug-Coated Balloon Sales by Application (2024-2029)
5.1.3 Global Peripheral Drug-Coated Balloon Sales Market Share by Application (2018-2029)
5.2 Global Peripheral Drug-Coated Balloon Revenue by Application (2018-2029)
5.2.1 Global Peripheral Drug-Coated Balloon Revenue by Application (2018-2023)
5.2.2 Global Peripheral Drug-Coated Balloon Revenue by Application (2024-2029)
5.2.3 Global Peripheral Drug-Coated Balloon Revenue Market Share by Application (2018-2029)
5.3 Global Peripheral Drug-Coated Balloon Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Cordis
6.1.1 Cordis Corporation Information
6.1.2 Cordis Description and Business Overview
6.1.3 Cordis Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Cordis Peripheral Drug-Coated Balloon Product Portfolio
6.1.5 Cordis Recent Developments/Updates
6.2 Defibtech
6.2.1 Defibtech Corporation Information
6.2.2 Defibtech Description and Business Overview
6.2.3 Defibtech Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Defibtech Peripheral Drug-Coated Balloon Product Portfolio
6.2.5 Defibtech Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abbott Laboratories Peripheral Drug-Coated Balloon Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 REVA Medical
6.4.1 REVA Medical Corporation Information
6.4.2 REVA Medical Description and Business Overview
6.4.3 REVA Medical Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.4.4 REVA Medical Peripheral Drug-Coated Balloon Product Portfolio
6.4.5 REVA Medical Recent Developments/Updates
6.5 Shimadzu
6.5.1 Shimadzu Corporation Information
6.5.2 Shimadzu Description and Business Overview
6.5.3 Shimadzu Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Shimadzu Peripheral Drug-Coated Balloon Product Portfolio
6.5.5 Shimadzu Recent Developments/Updates
6.6 Opto Circuits
6.6.1 Opto Circuits Corporation Information
6.6.2 Opto Circuits Description and Business Overview
6.6.3 Opto Circuits Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Opto Circuits Peripheral Drug-Coated Balloon Product Portfolio
6.6.5 Opto Circuits Recent Developments/Updates
6.7 Biotronik
6.6.1 Biotronik Corporation Information
6.6.2 Biotronik Description and Business Overview
6.6.3 Biotronik Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biotronik Peripheral Drug-Coated Balloon Product Portfolio
6.7.5 Biotronik Recent Developments/Updates
6.8 Endologix
6.8.1 Endologix Corporation Information
6.8.2 Endologix Description and Business Overview
6.8.3 Endologix Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Endologix Peripheral Drug-Coated Balloon Product Portfolio
6.8.5 Endologix Recent Developments/Updates
6.9 SMT
6.9.1 SMT Corporation Information
6.9.2 SMT Description and Business Overview
6.9.3 SMT Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.9.4 SMT Peripheral Drug-Coated Balloon Product Portfolio
6.9.5 SMT Recent Developments/Updates
6.10 Philips Healthcare
6.10.1 Philips Healthcare Corporation Information
6.10.2 Philips Healthcare Description and Business Overview
6.10.3 Philips Healthcare Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Philips Healthcare Peripheral Drug-Coated Balloon Product Portfolio
6.10.5 Philips Healthcare Recent Developments/Updates
6.11 Elixir Medical
6.11.1 Elixir Medical Corporation Information
6.11.2 Elixir Medical Peripheral Drug-Coated Balloon Description and Business Overview
6.11.3 Elixir Medical Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Elixir Medical Peripheral Drug-Coated Balloon Product Portfolio
6.11.5 Elixir Medical Recent Developments/Updates
6.12 CorMatrix Cardiovascular
6.12.1 CorMatrix Cardiovascular Corporation Information
6.12.2 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Description and Business Overview
6.12.3 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.12.4 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Product Portfolio
6.12.5 CorMatrix Cardiovascular Recent Developments/Updates
6.13 Advanced Cardiac Therapeutics
6.13.1 Advanced Cardiac Therapeutics Corporation Information
6.13.2 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Description and Business Overview
6.13.3 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Product Portfolio
6.13.5 Advanced Cardiac Therapeutics Recent Developments/Updates
6.14 Edwards Lifesciences
6.14.1 Edwards Lifesciences Corporation Information
6.14.2 Edwards Lifesciences Peripheral Drug-Coated Balloon Description and Business Overview
6.14.3 Edwards Lifesciences Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Edwards Lifesciences Peripheral Drug-Coated Balloon Product Portfolio
6.14.5 Edwards Lifesciences Recent Developments/Updates
6.15 Impulse Dynamics
6.15.1 Impulse Dynamics Corporation Information
6.15.2 Impulse Dynamics Peripheral Drug-Coated Balloon Description and Business Overview
6.15.3 Impulse Dynamics Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Impulse Dynamics Peripheral Drug-Coated Balloon Product Portfolio
6.15.5 Impulse Dynamics Recent Developments/Updates
6.16 Stereotaxis
6.16.1 Stereotaxis Corporation Information
6.16.2 Stereotaxis Peripheral Drug-Coated Balloon Description and Business Overview
6.16.3 Stereotaxis Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Stereotaxis Peripheral Drug-Coated Balloon Product Portfolio
6.16.5 Stereotaxis Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Peripheral Drug-Coated Balloon Industry Chain Analysis
7.2 Peripheral Drug-Coated Balloon Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peripheral Drug-Coated Balloon Production Mode & Process
7.4 Peripheral Drug-Coated Balloon Sales and Marketing
7.4.1 Peripheral Drug-Coated Balloon Sales Channels
7.4.2 Peripheral Drug-Coated Balloon Distributors
7.5 Peripheral Drug-Coated Balloon Customers
8 PERIPHERAL DRUG-COATED BALLOON MARKET DYNAMICS
8.1 Peripheral Drug-Coated Balloon Industry Trends
8.2 Peripheral Drug-Coated Balloon Market Drivers
8.3 Peripheral Drug-Coated Balloon Market Challenges
8.4 Peripheral Drug-Coated Balloon Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Peripheral Drug-Coated Balloon
1.2 Peripheral Drug-Coated Balloon Segment by Type
1.2.1 Global Peripheral Drug-Coated Balloon Market Value Comparison by Type (2023-2029)
1.2.2 Paclitaxel
1.2.3 Sirolimus
1.2.4 Others
1.3 Peripheral Drug-Coated Balloon Segment by Application
1.3.1 Global Peripheral Drug-Coated Balloon Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Peripheral Drug-Coated Balloon Market Size Estimates and Forecasts
1.4.1 Global Peripheral Drug-Coated Balloon Revenue 2018-2029
1.4.2 Global Peripheral Drug-Coated Balloon Sales 2018-2029
1.4.3 Global Peripheral Drug-Coated Balloon Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 PERIPHERAL DRUG-COATED BALLOON MARKET COMPETITION BY MANUFACTURERS
2.1 Global Peripheral Drug-Coated Balloon Sales Market Share by Manufacturers (2018-2023)
2.2 Global Peripheral Drug-Coated Balloon Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Peripheral Drug-Coated Balloon Average Price by Manufacturers (2018-2023)
2.4 Global Peripheral Drug-Coated Balloon Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Peripheral Drug-Coated Balloon, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peripheral Drug-Coated Balloon, Product Type & Application
2.7 Peripheral Drug-Coated Balloon Market Competitive Situation and Trends
2.7.1 Peripheral Drug-Coated Balloon Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Peripheral Drug-Coated Balloon Players Market Share by Revenue
2.7.3 Global Peripheral Drug-Coated Balloon Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PERIPHERAL DRUG-COATED BALLOON RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Peripheral Drug-Coated Balloon Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Peripheral Drug-Coated Balloon Global Peripheral Drug-Coated Balloon Sales by Region: 2018-2029
3.2.1 Global Peripheral Drug-Coated Balloon Sales by Region: 2018-2023
3.2.2 Global Peripheral Drug-Coated Balloon Sales by Region: 2024-2029
3.3 Global Peripheral Drug-Coated Balloon Global Peripheral Drug-Coated Balloon Revenue by Region: 2018-2029
3.3.1 Global Peripheral Drug-Coated Balloon Revenue by Region: 2018-2023
3.3.2 Global Peripheral Drug-Coated Balloon Revenue by Region: 2024-2029
3.4 North America Peripheral Drug-Coated Balloon Market Facts & Figures by Country
3.4.1 North America Peripheral Drug-Coated Balloon Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Peripheral Drug-Coated Balloon Sales by Country (2018-2029)
3.4.3 North America Peripheral Drug-Coated Balloon Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Peripheral Drug-Coated Balloon Market Facts & Figures by Country
3.5.1 Europe Peripheral Drug-Coated Balloon Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Peripheral Drug-Coated Balloon Sales by Country (2018-2029)
3.5.3 Europe Peripheral Drug-Coated Balloon Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peripheral Drug-Coated Balloon Market Facts & Figures by Country
3.6.1 Asia Pacific Peripheral Drug-Coated Balloon Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Peripheral Drug-Coated Balloon Sales by Country (2018-2029)
3.6.3 Asia Pacific Peripheral Drug-Coated Balloon Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Peripheral Drug-Coated Balloon Market Facts & Figures by Country
3.7.1 Latin America Peripheral Drug-Coated Balloon Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Peripheral Drug-Coated Balloon Sales by Country (2018-2029)
3.7.3 Latin America Peripheral Drug-Coated Balloon Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Peripheral Drug-Coated Balloon Market Facts & Figures by Country
3.8.1 Middle East and Africa Peripheral Drug-Coated Balloon Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Peripheral Drug-Coated Balloon Sales by Country (2018-2029)
3.8.3 Middle East and Africa Peripheral Drug-Coated Balloon Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Peripheral Drug-Coated Balloon Sales by Type (2018-2029)
4.1.1 Global Peripheral Drug-Coated Balloon Sales by Type (2018-2023)
4.1.2 Global Peripheral Drug-Coated Balloon Sales by Type (2024-2029)
4.1.3 Global Peripheral Drug-Coated Balloon Sales Market Share by Type (2018-2029)
4.2 Global Peripheral Drug-Coated Balloon Revenue by Type (2018-2029)
4.2.1 Global Peripheral Drug-Coated Balloon Revenue by Type (2018-2023)
4.2.2 Global Peripheral Drug-Coated Balloon Revenue by Type (2024-2029)
4.2.3 Global Peripheral Drug-Coated Balloon Revenue Market Share by Type (2018-2029)
4.3 Global Peripheral Drug-Coated Balloon Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Peripheral Drug-Coated Balloon Sales by Application (2018-2029)
5.1.1 Global Peripheral Drug-Coated Balloon Sales by Application (2018-2023)
5.1.2 Global Peripheral Drug-Coated Balloon Sales by Application (2024-2029)
5.1.3 Global Peripheral Drug-Coated Balloon Sales Market Share by Application (2018-2029)
5.2 Global Peripheral Drug-Coated Balloon Revenue by Application (2018-2029)
5.2.1 Global Peripheral Drug-Coated Balloon Revenue by Application (2018-2023)
5.2.2 Global Peripheral Drug-Coated Balloon Revenue by Application (2024-2029)
5.2.3 Global Peripheral Drug-Coated Balloon Revenue Market Share by Application (2018-2029)
5.3 Global Peripheral Drug-Coated Balloon Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Cordis
6.1.1 Cordis Corporation Information
6.1.2 Cordis Description and Business Overview
6.1.3 Cordis Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Cordis Peripheral Drug-Coated Balloon Product Portfolio
6.1.5 Cordis Recent Developments/Updates
6.2 Defibtech
6.2.1 Defibtech Corporation Information
6.2.2 Defibtech Description and Business Overview
6.2.3 Defibtech Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Defibtech Peripheral Drug-Coated Balloon Product Portfolio
6.2.5 Defibtech Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abbott Laboratories Peripheral Drug-Coated Balloon Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 REVA Medical
6.4.1 REVA Medical Corporation Information
6.4.2 REVA Medical Description and Business Overview
6.4.3 REVA Medical Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.4.4 REVA Medical Peripheral Drug-Coated Balloon Product Portfolio
6.4.5 REVA Medical Recent Developments/Updates
6.5 Shimadzu
6.5.1 Shimadzu Corporation Information
6.5.2 Shimadzu Description and Business Overview
6.5.3 Shimadzu Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Shimadzu Peripheral Drug-Coated Balloon Product Portfolio
6.5.5 Shimadzu Recent Developments/Updates
6.6 Opto Circuits
6.6.1 Opto Circuits Corporation Information
6.6.2 Opto Circuits Description and Business Overview
6.6.3 Opto Circuits Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Opto Circuits Peripheral Drug-Coated Balloon Product Portfolio
6.6.5 Opto Circuits Recent Developments/Updates
6.7 Biotronik
6.6.1 Biotronik Corporation Information
6.6.2 Biotronik Description and Business Overview
6.6.3 Biotronik Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biotronik Peripheral Drug-Coated Balloon Product Portfolio
6.7.5 Biotronik Recent Developments/Updates
6.8 Endologix
6.8.1 Endologix Corporation Information
6.8.2 Endologix Description and Business Overview
6.8.3 Endologix Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Endologix Peripheral Drug-Coated Balloon Product Portfolio
6.8.5 Endologix Recent Developments/Updates
6.9 SMT
6.9.1 SMT Corporation Information
6.9.2 SMT Description and Business Overview
6.9.3 SMT Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.9.4 SMT Peripheral Drug-Coated Balloon Product Portfolio
6.9.5 SMT Recent Developments/Updates
6.10 Philips Healthcare
6.10.1 Philips Healthcare Corporation Information
6.10.2 Philips Healthcare Description and Business Overview
6.10.3 Philips Healthcare Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Philips Healthcare Peripheral Drug-Coated Balloon Product Portfolio
6.10.5 Philips Healthcare Recent Developments/Updates
6.11 Elixir Medical
6.11.1 Elixir Medical Corporation Information
6.11.2 Elixir Medical Peripheral Drug-Coated Balloon Description and Business Overview
6.11.3 Elixir Medical Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Elixir Medical Peripheral Drug-Coated Balloon Product Portfolio
6.11.5 Elixir Medical Recent Developments/Updates
6.12 CorMatrix Cardiovascular
6.12.1 CorMatrix Cardiovascular Corporation Information
6.12.2 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Description and Business Overview
6.12.3 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.12.4 CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Product Portfolio
6.12.5 CorMatrix Cardiovascular Recent Developments/Updates
6.13 Advanced Cardiac Therapeutics
6.13.1 Advanced Cardiac Therapeutics Corporation Information
6.13.2 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Description and Business Overview
6.13.3 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Product Portfolio
6.13.5 Advanced Cardiac Therapeutics Recent Developments/Updates
6.14 Edwards Lifesciences
6.14.1 Edwards Lifesciences Corporation Information
6.14.2 Edwards Lifesciences Peripheral Drug-Coated Balloon Description and Business Overview
6.14.3 Edwards Lifesciences Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Edwards Lifesciences Peripheral Drug-Coated Balloon Product Portfolio
6.14.5 Edwards Lifesciences Recent Developments/Updates
6.15 Impulse Dynamics
6.15.1 Impulse Dynamics Corporation Information
6.15.2 Impulse Dynamics Peripheral Drug-Coated Balloon Description and Business Overview
6.15.3 Impulse Dynamics Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Impulse Dynamics Peripheral Drug-Coated Balloon Product Portfolio
6.15.5 Impulse Dynamics Recent Developments/Updates
6.16 Stereotaxis
6.16.1 Stereotaxis Corporation Information
6.16.2 Stereotaxis Peripheral Drug-Coated Balloon Description and Business Overview
6.16.3 Stereotaxis Peripheral Drug-Coated Balloon Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Stereotaxis Peripheral Drug-Coated Balloon Product Portfolio
6.16.5 Stereotaxis Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Peripheral Drug-Coated Balloon Industry Chain Analysis
7.2 Peripheral Drug-Coated Balloon Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peripheral Drug-Coated Balloon Production Mode & Process
7.4 Peripheral Drug-Coated Balloon Sales and Marketing
7.4.1 Peripheral Drug-Coated Balloon Sales Channels
7.4.2 Peripheral Drug-Coated Balloon Distributors
7.5 Peripheral Drug-Coated Balloon Customers
8 PERIPHERAL DRUG-COATED BALLOON MARKET DYNAMICS
8.1 Peripheral Drug-Coated Balloon Industry Trends
8.2 Peripheral Drug-Coated Balloon Market Drivers
8.3 Peripheral Drug-Coated Balloon Market Challenges
8.4 Peripheral Drug-Coated Balloon Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Peripheral Drug-Coated Balloon Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Peripheral Drug-Coated Balloon Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Peripheral Drug-Coated Balloon Market Competitive Situation by Manufacturers in 2022
Table 4. Global Peripheral Drug-Coated Balloon Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Peripheral Drug-Coated Balloon Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Peripheral Drug-Coated Balloon Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Peripheral Drug-Coated Balloon Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Peripheral Drug-Coated Balloon Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Peripheral Drug-Coated Balloon, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Peripheral Drug-Coated Balloon, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Peripheral Drug-Coated Balloon, Product Type & Application
Table 12. Global Key Manufacturers of Peripheral Drug-Coated Balloon, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peripheral Drug-Coated Balloon by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Drug-Coated Balloon as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Peripheral Drug-Coated Balloon Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Peripheral Drug-Coated Balloon Sales by Region (2018-2023) & (K Units)
Table 18. Global Peripheral Drug-Coated Balloon Sales Market Share by Region (2018-2023)
Table 19. Global Peripheral Drug-Coated Balloon Sales by Region (2024-2029) & (K Units)
Table 20. Global Peripheral Drug-Coated Balloon Sales Market Share by Region (2024-2029)
Table 21. Global Peripheral Drug-Coated Balloon Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Peripheral Drug-Coated Balloon Revenue Market Share by Region (2018-2023)
Table 23. Global Peripheral Drug-Coated Balloon Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Peripheral Drug-Coated Balloon Revenue Market Share by Region (2024-2029)
Table 25. North America Peripheral Drug-Coated Balloon Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Peripheral Drug-Coated Balloon Sales by Country (2018-2023) & (K Units)
Table 27. North America Peripheral Drug-Coated Balloon Sales by Country (2024-2029) & (K Units)
Table 28. North America Peripheral Drug-Coated Balloon Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Peripheral Drug-Coated Balloon Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Peripheral Drug-Coated Balloon Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Peripheral Drug-Coated Balloon Sales by Country (2018-2023) & (K Units)
Table 32. Europe Peripheral Drug-Coated Balloon Sales by Country (2024-2029) & (K Units)
Table 33. Europe Peripheral Drug-Coated Balloon Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Peripheral Drug-Coated Balloon Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Peripheral Drug-Coated Balloon Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Peripheral Drug-Coated Balloon Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Peripheral Drug-Coated Balloon Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Peripheral Drug-Coated Balloon Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Peripheral Drug-Coated Balloon Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Peripheral Drug-Coated Balloon Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Peripheral Drug-Coated Balloon Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Peripheral Drug-Coated Balloon Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Peripheral Drug-Coated Balloon Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Peripheral Drug-Coated Balloon Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Peripheral Drug-Coated Balloon Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Peripheral Drug-Coated Balloon Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Peripheral Drug-Coated Balloon Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Peripheral Drug-Coated Balloon Sales (K Units) by Type (2018-2023)
Table 51. Global Peripheral Drug-Coated Balloon Sales (K Units) by Type (2024-2029)
Table 52. Global Peripheral Drug-Coated Balloon Sales Market Share by Type (2018-2023)
Table 53. Global Peripheral Drug-Coated Balloon Sales Market Share by Type (2024-2029)
Table 54. Global Peripheral Drug-Coated Balloon Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Peripheral Drug-Coated Balloon Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Peripheral Drug-Coated Balloon Revenue Market Share by Type (2018-2023)
Table 57. Global Peripheral Drug-Coated Balloon Revenue Market Share by Type (2024-2029)
Table 58. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Type (2018-2023)
Table 59. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Type (2024-2029)
Table 60. Global Peripheral Drug-Coated Balloon Sales (K Units) by Application (2018-2023)
Table 61. Global Peripheral Drug-Coated Balloon Sales (K Units) by Application (2024-2029)
Table 62. Global Peripheral Drug-Coated Balloon Sales Market Share by Application (2018-2023)
Table 63. Global Peripheral Drug-Coated Balloon Sales Market Share by Application (2024-2029)
Table 64. Global Peripheral Drug-Coated Balloon Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Peripheral Drug-Coated Balloon Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Peripheral Drug-Coated Balloon Revenue Market Share by Application (2018-2023)
Table 67. Global Peripheral Drug-Coated Balloon Revenue Market Share by Application (2024-2029)
Table 68. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Application (2018-2023)
Table 69. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Application (2024-2029)
Table 70. Cordis Corporation Information
Table 71. Cordis Description and Business Overview
Table 72. Cordis Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Cordis Peripheral Drug-Coated Balloon Product
Table 74. Cordis Recent Developments/Updates
Table 75. Defibtech Corporation Information
Table 76. Defibtech Description and Business Overview
Table 77. Defibtech Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Defibtech Peripheral Drug-Coated Balloon Product
Table 79. Defibtech Recent Developments/Updates
Table 80. Abbott Laboratories Corporation Information
Table 81. Abbott Laboratories Description and Business Overview
Table 82. Abbott Laboratories Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Abbott Laboratories Peripheral Drug-Coated Balloon Product
Table 84. Abbott Laboratories Recent Developments/Updates
Table 85. REVA Medical Corporation Information
Table 86. REVA Medical Description and Business Overview
Table 87. REVA Medical Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. REVA Medical Peripheral Drug-Coated Balloon Product
Table 89. REVA Medical Recent Developments/Updates
Table 90. Shimadzu Corporation Information
Table 91. Shimadzu Description and Business Overview
Table 92. Shimadzu Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Shimadzu Peripheral Drug-Coated Balloon Product
Table 94. Shimadzu Recent Developments/Updates
Table 95. Opto Circuits Corporation Information
Table 96. Opto Circuits Description and Business Overview
Table 97. Opto Circuits Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Opto Circuits Peripheral Drug-Coated Balloon Product
Table 99. Opto Circuits Recent Developments/Updates
Table 100. Biotronik Corporation Information
Table 101. Biotronik Description and Business Overview
Table 102. Biotronik Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Biotronik Peripheral Drug-Coated Balloon Product
Table 104. Biotronik Recent Developments/Updates
Table 105. Endologix Corporation Information
Table 106. Endologix Description and Business Overview
Table 107. Endologix Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Endologix Peripheral Drug-Coated Balloon Product
Table 109. Endologix Recent Developments/Updates
Table 110. SMT Corporation Information
Table 111. SMT Description and Business Overview
Table 112. SMT Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. SMT Peripheral Drug-Coated Balloon Product
Table 114. SMT Recent Developments/Updates
Table 115. Philips Healthcare Corporation Information
Table 116. Philips Healthcare Description and Business Overview
Table 117. Philips Healthcare Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Philips Healthcare Peripheral Drug-Coated Balloon Product
Table 119. Philips Healthcare Recent Developments/Updates
Table 120. Elixir Medical Corporation Information
Table 121. Elixir Medical Description and Business Overview
Table 122. Elixir Medical Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Elixir Medical Peripheral Drug-Coated Balloon Product
Table 124. Elixir Medical Recent Developments/Updates
Table 125. CorMatrix Cardiovascular Corporation Information
Table 126. CorMatrix Cardiovascular Description and Business Overview
Table 127. CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Product
Table 129. CorMatrix Cardiovascular Recent Developments/Updates
Table 130. Advanced Cardiac Therapeutics Corporation Information
Table 131. Advanced Cardiac Therapeutics Description and Business Overview
Table 132. Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Product
Table 134. Advanced Cardiac Therapeutics Recent Developments/Updates
Table 135. Edwards Lifesciences Corporation Information
Table 136. Edwards Lifesciences Description and Business Overview
Table 137. Edwards Lifesciences Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Edwards Lifesciences Peripheral Drug-Coated Balloon Product
Table 139. Edwards Lifesciences Recent Developments/Updates
Table 140. Impulse Dynamics Corporation Information
Table 141. Impulse Dynamics Description and Business Overview
Table 142. Impulse Dynamics Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Impulse Dynamics Peripheral Drug-Coated Balloon Product
Table 144. Impulse Dynamics Recent Developments/Updates
Table 145. Stereotaxis Corporation Information
Table 146. Stereotaxis Description and Business Overview
Table 147. Stereotaxis Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Stereotaxis Peripheral Drug-Coated Balloon Product
Table 149. Stereotaxis Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Peripheral Drug-Coated Balloon Distributors List
Table 153. Peripheral Drug-Coated Balloon Customers List
Table 154. Peripheral Drug-Coated Balloon Market Trends
Table 155. Peripheral Drug-Coated Balloon Market Drivers
Table 156. Peripheral Drug-Coated Balloon Market Challenges
Table 157. Peripheral Drug-Coated Balloon Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 1. Global Peripheral Drug-Coated Balloon Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Peripheral Drug-Coated Balloon Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Peripheral Drug-Coated Balloon Market Competitive Situation by Manufacturers in 2022
Table 4. Global Peripheral Drug-Coated Balloon Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Peripheral Drug-Coated Balloon Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Peripheral Drug-Coated Balloon Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Peripheral Drug-Coated Balloon Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Peripheral Drug-Coated Balloon Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Peripheral Drug-Coated Balloon, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Peripheral Drug-Coated Balloon, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Peripheral Drug-Coated Balloon, Product Type & Application
Table 12. Global Key Manufacturers of Peripheral Drug-Coated Balloon, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peripheral Drug-Coated Balloon by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Drug-Coated Balloon as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Peripheral Drug-Coated Balloon Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Peripheral Drug-Coated Balloon Sales by Region (2018-2023) & (K Units)
Table 18. Global Peripheral Drug-Coated Balloon Sales Market Share by Region (2018-2023)
Table 19. Global Peripheral Drug-Coated Balloon Sales by Region (2024-2029) & (K Units)
Table 20. Global Peripheral Drug-Coated Balloon Sales Market Share by Region (2024-2029)
Table 21. Global Peripheral Drug-Coated Balloon Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Peripheral Drug-Coated Balloon Revenue Market Share by Region (2018-2023)
Table 23. Global Peripheral Drug-Coated Balloon Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Peripheral Drug-Coated Balloon Revenue Market Share by Region (2024-2029)
Table 25. North America Peripheral Drug-Coated Balloon Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Peripheral Drug-Coated Balloon Sales by Country (2018-2023) & (K Units)
Table 27. North America Peripheral Drug-Coated Balloon Sales by Country (2024-2029) & (K Units)
Table 28. North America Peripheral Drug-Coated Balloon Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Peripheral Drug-Coated Balloon Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Peripheral Drug-Coated Balloon Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Peripheral Drug-Coated Balloon Sales by Country (2018-2023) & (K Units)
Table 32. Europe Peripheral Drug-Coated Balloon Sales by Country (2024-2029) & (K Units)
Table 33. Europe Peripheral Drug-Coated Balloon Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Peripheral Drug-Coated Balloon Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Peripheral Drug-Coated Balloon Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Peripheral Drug-Coated Balloon Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Peripheral Drug-Coated Balloon Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Peripheral Drug-Coated Balloon Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Peripheral Drug-Coated Balloon Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Peripheral Drug-Coated Balloon Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Peripheral Drug-Coated Balloon Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Peripheral Drug-Coated Balloon Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Peripheral Drug-Coated Balloon Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Peripheral Drug-Coated Balloon Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Peripheral Drug-Coated Balloon Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Peripheral Drug-Coated Balloon Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Peripheral Drug-Coated Balloon Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Peripheral Drug-Coated Balloon Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Peripheral Drug-Coated Balloon Sales (K Units) by Type (2018-2023)
Table 51. Global Peripheral Drug-Coated Balloon Sales (K Units) by Type (2024-2029)
Table 52. Global Peripheral Drug-Coated Balloon Sales Market Share by Type (2018-2023)
Table 53. Global Peripheral Drug-Coated Balloon Sales Market Share by Type (2024-2029)
Table 54. Global Peripheral Drug-Coated Balloon Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Peripheral Drug-Coated Balloon Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Peripheral Drug-Coated Balloon Revenue Market Share by Type (2018-2023)
Table 57. Global Peripheral Drug-Coated Balloon Revenue Market Share by Type (2024-2029)
Table 58. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Type (2018-2023)
Table 59. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Type (2024-2029)
Table 60. Global Peripheral Drug-Coated Balloon Sales (K Units) by Application (2018-2023)
Table 61. Global Peripheral Drug-Coated Balloon Sales (K Units) by Application (2024-2029)
Table 62. Global Peripheral Drug-Coated Balloon Sales Market Share by Application (2018-2023)
Table 63. Global Peripheral Drug-Coated Balloon Sales Market Share by Application (2024-2029)
Table 64. Global Peripheral Drug-Coated Balloon Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Peripheral Drug-Coated Balloon Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Peripheral Drug-Coated Balloon Revenue Market Share by Application (2018-2023)
Table 67. Global Peripheral Drug-Coated Balloon Revenue Market Share by Application (2024-2029)
Table 68. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Application (2018-2023)
Table 69. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Application (2024-2029)
Table 70. Cordis Corporation Information
Table 71. Cordis Description and Business Overview
Table 72. Cordis Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Cordis Peripheral Drug-Coated Balloon Product
Table 74. Cordis Recent Developments/Updates
Table 75. Defibtech Corporation Information
Table 76. Defibtech Description and Business Overview
Table 77. Defibtech Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Defibtech Peripheral Drug-Coated Balloon Product
Table 79. Defibtech Recent Developments/Updates
Table 80. Abbott Laboratories Corporation Information
Table 81. Abbott Laboratories Description and Business Overview
Table 82. Abbott Laboratories Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Abbott Laboratories Peripheral Drug-Coated Balloon Product
Table 84. Abbott Laboratories Recent Developments/Updates
Table 85. REVA Medical Corporation Information
Table 86. REVA Medical Description and Business Overview
Table 87. REVA Medical Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. REVA Medical Peripheral Drug-Coated Balloon Product
Table 89. REVA Medical Recent Developments/Updates
Table 90. Shimadzu Corporation Information
Table 91. Shimadzu Description and Business Overview
Table 92. Shimadzu Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Shimadzu Peripheral Drug-Coated Balloon Product
Table 94. Shimadzu Recent Developments/Updates
Table 95. Opto Circuits Corporation Information
Table 96. Opto Circuits Description and Business Overview
Table 97. Opto Circuits Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Opto Circuits Peripheral Drug-Coated Balloon Product
Table 99. Opto Circuits Recent Developments/Updates
Table 100. Biotronik Corporation Information
Table 101. Biotronik Description and Business Overview
Table 102. Biotronik Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Biotronik Peripheral Drug-Coated Balloon Product
Table 104. Biotronik Recent Developments/Updates
Table 105. Endologix Corporation Information
Table 106. Endologix Description and Business Overview
Table 107. Endologix Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Endologix Peripheral Drug-Coated Balloon Product
Table 109. Endologix Recent Developments/Updates
Table 110. SMT Corporation Information
Table 111. SMT Description and Business Overview
Table 112. SMT Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. SMT Peripheral Drug-Coated Balloon Product
Table 114. SMT Recent Developments/Updates
Table 115. Philips Healthcare Corporation Information
Table 116. Philips Healthcare Description and Business Overview
Table 117. Philips Healthcare Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Philips Healthcare Peripheral Drug-Coated Balloon Product
Table 119. Philips Healthcare Recent Developments/Updates
Table 120. Elixir Medical Corporation Information
Table 121. Elixir Medical Description and Business Overview
Table 122. Elixir Medical Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Elixir Medical Peripheral Drug-Coated Balloon Product
Table 124. Elixir Medical Recent Developments/Updates
Table 125. CorMatrix Cardiovascular Corporation Information
Table 126. CorMatrix Cardiovascular Description and Business Overview
Table 127. CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. CorMatrix Cardiovascular Peripheral Drug-Coated Balloon Product
Table 129. CorMatrix Cardiovascular Recent Developments/Updates
Table 130. Advanced Cardiac Therapeutics Corporation Information
Table 131. Advanced Cardiac Therapeutics Description and Business Overview
Table 132. Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Advanced Cardiac Therapeutics Peripheral Drug-Coated Balloon Product
Table 134. Advanced Cardiac Therapeutics Recent Developments/Updates
Table 135. Edwards Lifesciences Corporation Information
Table 136. Edwards Lifesciences Description and Business Overview
Table 137. Edwards Lifesciences Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Edwards Lifesciences Peripheral Drug-Coated Balloon Product
Table 139. Edwards Lifesciences Recent Developments/Updates
Table 140. Impulse Dynamics Corporation Information
Table 141. Impulse Dynamics Description and Business Overview
Table 142. Impulse Dynamics Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Impulse Dynamics Peripheral Drug-Coated Balloon Product
Table 144. Impulse Dynamics Recent Developments/Updates
Table 145. Stereotaxis Corporation Information
Table 146. Stereotaxis Description and Business Overview
Table 147. Stereotaxis Peripheral Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Stereotaxis Peripheral Drug-Coated Balloon Product
Table 149. Stereotaxis Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Peripheral Drug-Coated Balloon Distributors List
Table 153. Peripheral Drug-Coated Balloon Customers List
Table 154. Peripheral Drug-Coated Balloon Market Trends
Table 155. Peripheral Drug-Coated Balloon Market Drivers
Table 156. Peripheral Drug-Coated Balloon Market Challenges
Table 157. Peripheral Drug-Coated Balloon Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Peripheral Drug-Coated Balloon
Figure 2. Global Peripheral Drug-Coated Balloon Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Peripheral Drug-Coated Balloon Market Share by Type in 2022 & 2029
Figure 4. Paclitaxel Product Picture
Figure 5. Sirolimus Product Picture
Figure 6. Others Product Picture
Figure 7. Global Peripheral Drug-Coated Balloon Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Peripheral Drug-Coated Balloon Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Peripheral Drug-Coated Balloon Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Peripheral Drug-Coated Balloon Market Size (2018-2029) & (US$ Million)
Figure 14. Global Peripheral Drug-Coated Balloon Sales (2018-2029) & (K Units)
Figure 15. Global Peripheral Drug-Coated Balloon Average Price (US$/Unit) & (2018-2029)
Figure 16. Peripheral Drug-Coated Balloon Report Years Considered
Figure 17. Peripheral Drug-Coated Balloon Sales Share by Manufacturers in 2022
Figure 18. Global Peripheral Drug-Coated Balloon Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Peripheral Drug-Coated Balloon Players: Market Share by Revenue in 2022
Figure 20. Peripheral Drug-Coated Balloon Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Peripheral Drug-Coated Balloon Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Peripheral Drug-Coated Balloon Sales Market Share by Country (2018-2029)
Figure 23. North America Peripheral Drug-Coated Balloon Revenue Market Share by Country (2018-2029)
Figure 24. United States Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Peripheral Drug-Coated Balloon Sales Market Share by Country (2018-2029)
Figure 27. Europe Peripheral Drug-Coated Balloon Revenue Market Share by Country (2018-2029)
Figure 28. Germany Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Peripheral Drug-Coated Balloon Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Peripheral Drug-Coated Balloon Revenue Market Share by Region (2018-2029)
Figure 35. China Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Peripheral Drug-Coated Balloon Sales Market Share by Country (2018-2029)
Figure 45. Latin America Peripheral Drug-Coated Balloon Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Colombia Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Peripheral Drug-Coated Balloon Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Peripheral Drug-Coated Balloon by Type (2018-2029)
Figure 56. Global Revenue Market Share of Peripheral Drug-Coated Balloon by Type (2018-2029)
Figure 57. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Peripheral Drug-Coated Balloon by Application (2018-2029)
Figure 59. Global Revenue Market Share of Peripheral Drug-Coated Balloon by Application (2018-2029)
Figure 60. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Application (2018-2029)
Figure 61. Peripheral Drug-Coated Balloon Value Chain
Figure 62. Peripheral Drug-Coated Balloon Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Figure 1. Product Picture of Peripheral Drug-Coated Balloon
Figure 2. Global Peripheral Drug-Coated Balloon Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Peripheral Drug-Coated Balloon Market Share by Type in 2022 & 2029
Figure 4. Paclitaxel Product Picture
Figure 5. Sirolimus Product Picture
Figure 6. Others Product Picture
Figure 7. Global Peripheral Drug-Coated Balloon Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Peripheral Drug-Coated Balloon Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Peripheral Drug-Coated Balloon Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Peripheral Drug-Coated Balloon Market Size (2018-2029) & (US$ Million)
Figure 14. Global Peripheral Drug-Coated Balloon Sales (2018-2029) & (K Units)
Figure 15. Global Peripheral Drug-Coated Balloon Average Price (US$/Unit) & (2018-2029)
Figure 16. Peripheral Drug-Coated Balloon Report Years Considered
Figure 17. Peripheral Drug-Coated Balloon Sales Share by Manufacturers in 2022
Figure 18. Global Peripheral Drug-Coated Balloon Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Peripheral Drug-Coated Balloon Players: Market Share by Revenue in 2022
Figure 20. Peripheral Drug-Coated Balloon Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Peripheral Drug-Coated Balloon Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Peripheral Drug-Coated Balloon Sales Market Share by Country (2018-2029)
Figure 23. North America Peripheral Drug-Coated Balloon Revenue Market Share by Country (2018-2029)
Figure 24. United States Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Peripheral Drug-Coated Balloon Sales Market Share by Country (2018-2029)
Figure 27. Europe Peripheral Drug-Coated Balloon Revenue Market Share by Country (2018-2029)
Figure 28. Germany Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Peripheral Drug-Coated Balloon Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Peripheral Drug-Coated Balloon Revenue Market Share by Region (2018-2029)
Figure 35. China Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Peripheral Drug-Coated Balloon Sales Market Share by Country (2018-2029)
Figure 45. Latin America Peripheral Drug-Coated Balloon Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Colombia Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Peripheral Drug-Coated Balloon Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Peripheral Drug-Coated Balloon Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Peripheral Drug-Coated Balloon Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Peripheral Drug-Coated Balloon by Type (2018-2029)
Figure 56. Global Revenue Market Share of Peripheral Drug-Coated Balloon by Type (2018-2029)
Figure 57. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Peripheral Drug-Coated Balloon by Application (2018-2029)
Figure 59. Global Revenue Market Share of Peripheral Drug-Coated Balloon by Application (2018-2029)
Figure 60. Global Peripheral Drug-Coated Balloon Price (US$/Unit) by Application (2018-2029)
Figure 61. Peripheral Drug-Coated Balloon Value Chain
Figure 62. Peripheral Drug-Coated Balloon Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
